Search

everythinglearnresearchcommunity

for

Search:↓

Liposomes can make the antiandrogen RU 58841 more effective for skin application by reducing absorption, increasing skin retention, and targeting sebaceous structures.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Finasteride and dutasteride are effective for male hair loss and enlarged prostate but may cause reversible sexual side effects.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Some natural compounds from Iris plants can block enzymes related to certain disorders, with a few affecting both targeted enzymes.

RU 58841 may treat acne, hair loss, and excessive hair growth.

Urologists prescribe newer medications more often than primary care physicians, who could benefit from more education on treatment options.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Urtica laetevirens extract significantly reduces 5α-reductase activity.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

Plant extracts effectively reduce hair loss and increase growth, offering a safe alternative treatment.

Rats had lasting erectile problems after stopping a certain medication.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Certain inhibitors slow down plant growth by causing early cell specialization without changing the cell development pattern.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

A new treatment for hair loss shows promise with fewer side effects.

Adenosine boosts hair growth by increasing angiogenin levels.

The study found that certain mutations in the vitamin D receptor can cause rickets and potentially affect hair growth.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.